Selection · adults and children
1 finding from 1 review
Consumption · adults and children
1 finding from 1 review
Menstrual regularity ‐ LOD vs unilateral LOD N of participants: 104 (2 RCTs) · Women with symptoms of PCOS
LOD 4‐5 may leads to higher menstrual regularity at 6 months ‐ LOD (4 ‐ 5 laser coagulation… compared with 2 or fewer punctures (low certainty).
1 finding from 1 review
OR 19 [2.12, 170.38]
Studies not reported
Low
Improvement in androgenic symptoms · Women with symptoms of PCOS
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Death · patients with leading to fewer clinical adverse events
The intervention showed no clear difference in death (low certainty).
1 finding from 1 review
Intervention not reported
Anticoagulants: events ‐ bleeding · patients with leading to fewer clinical adverse events
The intervention showed no clear difference in anticoagulants: events ‐ bleeding (low certainty).
1 finding from 1 review
Intervention not reported
Anticoagulants: events ‐ thromboembolism · patients with leading to fewer clinical adverse events
It is very uncertain whether the intervention changes anticoagulants: events ‐ thromboembolism (very low certainty).
1 finding from 1 review
Intervention not reported
Insulin ‐ hypoglycaemia (< 60 mg/dL) · patients with leading to fewer clinical adverse events
The intervention showed no clear difference in insulin ‐ hypoglycaemia (< 60 mg/dL) (low certainty).
1 finding from 1 review
Intervention not reported
Insulin ‐ severe hypoglycaemia (< 40 mg/dL) · patients with leading to fewer clinical adverse events
It is very uncertain whether the intervention changes insulin ‐ severe hypoglycaemia (< 40 mg/dL) (very low certainty).
1 finding from 1 review
Intervention not reported
Aminoglycoside antibiotics ‐ nephrotoxicity · patients with leading to fewer clinical adverse events
The intervention showed no clear difference in aminoglycoside antibiotics ‐ nephrotoxicity (low certainty).
1 finding from 1 review
Stroke · preventing early recurrence after ischaemic stroke or TIA
Dual probably leads to lower stroke compared with one antiplatelet agent (moderate certainty).
1 finding from 1 review
Deaths due to vascular events · preventing early recurrence after ischaemic stroke or TIA
Dual showed no clear difference in vascular death compared with one antiplatelet agent (moderate certainty).
1 finding from 1 review
Myocardial infarction · preventing early recurrence after ischaemic stroke or TIA
Dual showed no clear difference in myocardial infarction compared with one antiplatelet agent (high certainty).
1 finding from 1 review
Stroke, myocardial infarction, or vascular death · preventing early recurrence after ischaemic stroke or TIA
Dual probably leads to lower stroke, myocardial infarction, or vascular death compared with one antiplatelet agent (moderate certainty).
1 finding from 1 review
Intracranial haemorrhage · preventing early recurrence after ischaemic stroke or TIA
Dual showed no clear difference in intracranial haemorrhage compared with one antiplatelet agent (low certainty).
1 finding from 1 review
Extracranial haemorrhage · preventing early recurrence after ischaemic stroke or TIA
Dual leads to higher extracranial haemorrhage compared with one antiplatelet agent (high certainty).
1 finding from 1 review
Ischaemic stroke · preventing early recurrence after ischaemic stroke or TIA
Dual leads to lower ischaemic stroke compared with one antiplatelet agent (high certainty).
1 finding from 1 review
Outcomes at ≥ 3 months · preventing early recurrence after ischaemic stroke or TIA
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found